Pet Diabetes Care Market Trends and Demand Outlook 2026–2030

April 8, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Anticholinergic Drugs Market Over The 2026–2030 Period?

The pet diabetes care market has experienced significant expansion in recent years. It is forecast to rise from $2.4 billion in 2025 to $2.63 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.5%. The market’s historical growth can be attributed to the increasing prevalence of diabetes among companion animals, the development of standard insulin therapies for pets, the growth of veterinary clinic infrastructures, advances in diagnostic tools for pet diabetes, and an increase in pet ownership.

The pet diabetes care market size is projected to experience substantial growth in the upcoming years. It is forecast to grow to $3.8 billion in 2030, achieving a compound annual growth rate (CAGR) of 9.6%. The expansion anticipated during the forecast period can be attributed to the advancement of smart insulin delivery devices, the broadening of home-based monitoring solutions, an increase in the adoption of telemedicine platforms, greater investment in veterinary endocrinology research, and the expanding availability of species-specific oral medications. Prominent trends expected in this period include a rising uptake of insulin therapy in pets, the development of at-home glucose monitoring for animals, heightened awareness of diabetes management in companion animals, the integration of telemedicine for pet diabetes care, and the creation of species-specific oral hypoglycemic drugs.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8095&type=smp

What Drivers Are Expected To Influence The Anticholinergic Drugs Market During The Forecast Period?

The pet diabetes care market is projected to expand due to the increasing demand for pet insurance. Pet insurance provides financial security, covering a portion of veterinary expenses for pets and assisting owners with healthcare costs. The surge in pet insurance adoption stems from escalating veterinary treatment expenses, prompting owners to seek financial safeguards against unforeseen medical bills and to guarantee prompt care for their animals. Pet diabetes care benefits pet insurance by facilitating early detection and ongoing management, thereby minimizing emergency complications and costly treatments, which leads to more stable and sustainable insurance claims. For example, in April 2025, data from the North American Pet Health Insurance Association (NAPHIA), a US-based pet health insurance trade organization, showed that the number of insured pets in North America reached 7.0 million in 2024, an increase from 6.25 million in 2023 (a 12.2% rise). This data underscores the rapid growth in pet insurance demand as owners look for financial protection against rising veterinary costs. Consequently, the increasing need for pet insurance is fueling the growth of the pet diabetes care market.

How Is The Anticholinergic Drugs Market Segmented Across Key Categories?

The pet diabetes care market covered in this report is segmented –

1) By Drug Type: Insulin Therapy, Oral Medication

2) By Device Type: Glucose Monitoring Devices, Insulin Delivery Devices

3) By Animal Type: Canine, Feline, Other Animal Types

4) By End-User: Veterinary Clinics, Home Care Settings, Veterinary Hospitals

Subsegments:

1) By Insulin Therapy: Canine Insulin Products, Feline Insulin Products, Insulin Delivery Devices

2) By Oral Medication: Glipizide, Metformin

Which Upcoming Trends Are Expected To Influence The Pet Diabetes Care Market?

Major companies operating in the pet diabetes care market are concentrating on innovating technological products, such as the Petrackr diabetes monitoring device, to provide reliable services to customers. The Petrackr diabetes monitoring device functions as a veterinary blood glucometer specifically designed to monitor diabetes in cats and dogs. For instance, in May 2023, Universal Biosensors Inc., an Australia-based biosensor company, launched the Petrackr diabetes monitoring device. This device delivers blood glucose test results in just seconds and is easy for pet parents and veterinary clinicians to utilize. It is also compatible with the Petrackr app, which enables users to easily record, monitor, and report results.

Who Are The Dominant Players Shaping The Anticholinergic Drugs Market Landscape?

Major companies operating in the pet diabetes care market are C.H. Boehringer Sohn AG & Co. KG, Becton Dickinson and Company, Merck & Co Inc., Zoetis Inc., Trividia Health Inc., Allison Medical Inc., UltiMed Inc., Apotex Inc., Henry Schein VET GmbH, Medtrust Holdings Inc., i-SENS Inc., Taidoc Technology Corp., Covetrus Inc., ALR Technologies Inc., Vet Innovations Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, AgaMatrix Inc., Ascensia Diabetes Care Holdings AG, Bayer AG, Dexcom Inc., LifeScan Inc., Medtronic PLC, Novo Nordisk A/S, Sanofi S.A., Senseonics Holdings Inc., Tandem Diabetes Care Inc., Terumo Corporation, Animas Corporation, Insulet Corporation, Roche Diabetes Care Inc.

Read the full pet diabetes care market report here:

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report

Which Region Is Forecast To Lead The Anticholinergic Drugs Market In Terms Of Market Size?

North America was the largest region in the pet diabetes care market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pet diabetes care market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Anticholinergic Drugs Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8095&type=smp

Browse Through More Reports Similar to the Global Pet Diabetes Care Market 2026, By The Business Research Company

Pet Diabetes Care Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report

Diabetes Care Devices Market 2026

https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-market

Continuous Glucose Monitoring Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/continuous-glucose-monitoring-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795